The heterotrimeric G-protein pathway controls numerous cellular processes, including proliferation, differentiation, migration, membrane trafficking, and embryonic development. Regulator of G-protein signaling (RGS) proteins are known to function at the G-protein level. Here, the functional role of a novel RGS protein, regulator of G-protein signaling 22 (RGS22), in the testis was investigated at the mRNA and protein levels. Our results demonstrate that RGS22 is a testis-specific gene. However, significantly decreased expression of RGS22 was found in the testes of patients with azoospermia. RGS22 was translated or posttranslationally modified into multiple proteins of different molecular sizes in prokaryocytes as well as in the testes. Its protein (NP_056483) was localized in spermatogenic cells and Leydig cells and could interact with guanine nucleotide binding protein, alpha 12, 13, and 11 (GNA12, GNA13, and GNA11). Fragmental GFP-fusion protein tracking revealed that the N-terminal of RGS22 was localized in the nucleus. RGS22 and GNA13 were localized in the nucleus from the elongated spermatid stage onward. Indirect immunofluorescence studies revealed defective expression of GNA13 in macrocephalic and global nucleus spermatozoa. These findings suggest that their functions in this subcellular compartment are likely related to the postmeiotic developmental phase, spermiogenesis. RGS22 may also play a role in GNA13 translocation from the cytoplasm to the nucleus during spermiogenesis.
INTRODUCTION
Heterotrimeric G proteins relay extracellular signals from hormones, chemokines, neurotransmitters, and sensory stimuli to intracellular effectors via G protein-coupled receptors, thus triggering a variety of physiological responses. Regulators of Gprotein signaling (RGS) proteins are a diverse family of proteins that function as negative regulators of heterotrimeric G-protein signaling. They bind to activated Ga subunits and function as GTPase-activating proteins (GAPs) by accelerating the hydrolysis of GTP to GDP. Since the initial discovery of an RGS protein in Saccharomyces cerevisiae, 37 genes that encode proteins containing an RGS or RGS-like domain have been identified within the human genome [1] . All identified RGS proteins contain a conserved region of ;120 residues, which is referred to as the RGS domain. Despite this common core domain, RGS family members differ greatly with respect to size, sequence, cellular localization, and tissue distribution [2] . Recent experimental data suggest that RGS proteins are involved in regulating a variety of cellular processes modulated by G-protein signaling, including proliferation, differentiation, migration, membrane trafficking, and embryonic development [3] .
Several reports have examined the expression of RGS proteins in the testis. For instance, G protein-coupled receptor kinases (GRKs) and dual-specific A kinase-anchoring protein 2, AKAP10 (also known as D-AKAP2), are expressed in the mouse testis [4] [5] [6] . Further studies demonstrated that ADRBK1 (also known as GRK2) is recruited to FSH receptors in stimulated primary rat Sertoli cells [5] , and GRK4 is expressed in spermatozoa and germinal cells, where it is associated with mitochondrial and acrosomal membranes [4] . Here, we report a new RGS gene, regulator of G-protein signaling 22 (RGS22) , that is specifically expressed in the human and mouse testis during different stages of development. It could be produced in different sizes and structures both in prokaryocytes and in the testes. Furthermore, RGS22 was shown to interact with the Gprotein a subunits 12, 13, and q/11 in the mouse testis.
The localization of RGS proteins at or near the plasma membrane, where G proteins as well as receptors and effectors are located, is intrinsic to their proposed regulatory actions [7] . Here, we examined the cellular localization of endogenous RGS22 in spermatogenic cells and as GFP fusion proteins in mouse spermatogenic cell lines. Our results revealed diversity in the subcellular localization and trafficking of RGS22. It was observed to be localized in both the cytoplasm and nucleus. Moreover, we identified the N-terminal as the molecular determinant for nuclear localization of RGS22.
MATERIALS AND METHODS

Human Samples
Prior to sample collection, approval was granted by the Committee of Nanjing Medical University on Human Rights in Research, and all participants were provided written consent. Seminal specimens were obtained from healthy adult males. The volume, pH, cell number, percentage of motile sperm, and percentage of abnormal sperm were determined for each specimen. Only samples meeting the World Health Organization criteria [8] were used as normal samples. Normal human testis specimens were obtained from healthy volunteers. After semen samples were obtained and their normality confirmed over three examinations, testicular tissue samples were taken during biopsy and frozen or made into paraffin sections. The testicular specimens of 19 patients with azoospermia (Table 1) were obtained from clinical biopsies for pathological diagnosis after informed consent. Histological structures were examined by hematoxylin-eosin (HE) staining. To determine whether GNA13 protein was associated with specific types of sperm abnormalities, seminal specimens were obtained from healthy adult males (n ¼ 6) and from patients with teratospermia (n ¼ 6) for comparison.
RNA Isolation and RT-PCR Analysis
Multiple tissue cDNA panels were purchased from Clontech Laboratories (#1420-1; Palo Alto, CA), including testis, thymus, small intestine, colon, spleen, leukocyte, prostate gland, ovary, pancreas, heart, kidney, lung, placenta, liver, brain, and skeletal muscle. The RGS22 primers were synthesized by Biocolor (Shanghai, China) as follows: upstream: 5 0 -GGCACCAA-GATTCTGTGTTA-3 0 , and downstream: 5 0 -AAGTTATTCTCCG-GAACTGC-3 0 . The PCR product was 1163 bp in size. PCR conditions were as follows: denaturing at 948C for 30 sec, annealing at 558C for 30 sec, and extension at 728C for 1 min. The first cycle was a denaturing period of 5 min. The last cycle had an extension period of 7 min. Thirty-five cycles of PCR were performed. GAPDH was used as a positive control. Its upstream primer was 5 0 -TGAAGGTCGGAGTCAACGGATTTGGT-3 0 , and the downstream primer was 5 0 -CATGTGGGCCATGAGGTCCACCAC-3 0 . The designed fragments were 983 bp. The PCR mixture was the same as above except for the primers. PCR conditions were performed according to the manufacturer's instructions (Clontech #1420-1): denaturing at 958C for 1 min, annealing and extension at 688C for 1 min. The first cycle had a denaturing period of 5 min. The last cycle had an extension period of 3 min. Thirty-five cycles of PCR were performed.
Total RNA of testis specimens of 19 patients with azoospermia were isolated separately using Trizol reagent (Gibco BRL, Grand Island, NY). The Poly (A)þ mRNA was purified using an affinity column filled with Poly (dT) resin (Qiagen, Hilden, German). Reverse transcription was performed in 15 ll of reaction mixture. First, 1 ll of total RNA,1 ll random primer (0.2 lg/ml; Shengong, Shanghai, China), and 7 ll DEPC water were mixed and incubated at 708C for 5 min, then 3 ll 53 M-MLV RT buffer, 0.75 ll dNTP (20 mM), 0.35 ll Rnasin (50 U/ll), 1 ll M-MLV reverse transcriptase (all from Promega), and 1 ll DEPC water were added and incubated at 378C for 1 h and then 958C for 5 min.
The RGS22 primers were as follows: upstream: 5 0 -TCCCATTTAT-GATGTTGTAAGG-3 0 , and downstream: 5 0 -GAGGTGGTAGACTGGG-TGG-3 0 . The PCR product was 388 bp in size. Human b-actin was used as a control. Its upstream primer was 5 0 -CGGTTGGCCTTGGGGTTCAGGGGG-3 0 , and the downstream primer was 5 0 -ATCGTGGGGGCGCCCCAGGCAC-CA-3 0 . PCR conditions were as follows: denaturing at 948C for 30 sec, annealing at 558C for 30 sec, and extension at 728C for 30 sec. The first cycle was a denaturing period of 5 min. The last cycle had an extension period of 7 min. Thirty-five cycles of PCR were performed.
Recombinant Protein Expression and Purification
The Escherichia coli strain BL21DE3 was transformed with PET22b-RGS22, induced with IPTG, harvested, and resuspended as described previously [9] . The bacteria were sonicated and centrifuged, and the supernatant was purified by AKTA Basic (Amersham Biosciences, Uppsala, Sweden) according to the manufacturer's protocol. Purified His-RGS22 was refolded by dialysis using a decreasing gradient of urea buffer (6, 4, 2, and 0 M).
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis
The bands obtained were excised from gels stained with Coomassie brilliant blue along with one control spot in the nonstained gel area. The gel-bound proteins were subjected to in-gel protein digestion and sample preparation for matrix-assisted laser desorption/ionization mass spectrometry, as described by Zhu et al. [10] . Statistical analysis data obtained for the protein spots were screened against the SWISS-PROT database using the MASCOT search engine [11, 12] . The searches were carried out with a peptide mass accuracy tolerance of 100 ppm for external calibration. The peptides detected in the blank controls were excluded. The search criteria used were as follows: one missed cleavage per peptide and variable modifications of carbamidomethyl (C).
Production and Purification of Polyclonal Mouse
Anti-RGS22 Antibodies BALB/c mice were injected with purified recombinant RGS22 protein. The antibody was purified by affinity chromatography using PROSEP-G Antibody Purification Kits (Millipore, Billerica, MA).
Separation of Human Spermatozoa
Spermatozoa were separated according to the methods of Gandini [13] , with little modification. In brief, Percoll (Sigma Chemical Co., St. Louis, MO) was diluted to 60% with PBS. Semen (1 ml or the whole semen sample in cases where less than 1 ml of ejaculate was obtained) was diluted with PBS (1:2) and centrifuged at 400 3 g for 15 min at 188C. The semen cell pellet was resuspended and gently stratified on top of the Percoll gradient and centrifuged at 800 3 g for 25 min at 188C. The single Percoll fractions were separated and washed in PBS three times, and the pellet was subsequently resuspended in PBS. The film preparation with the cell suspension was observed using light microscopy to ensure that no immature germ cells were present.
Protein Extraction and Western Blot Analysis
Protein extracts were prepared by treating tissues or spermatozoa with lysis buffer (7 M urea, 2 M thiourea, 4% [w/v] CHAPS, 2% [w/v] dithiothreitol] in the presence of a protease inhibitor cocktail. The mixture was centrifuged at 12 000 3 g for 1 h at 48C, and the supernatant was collected and stored at À708C. Protein concentration was estimated by the Bradford method using BSA as the standard.
Samples containing 100 lg of protein from normal human testes, mouse brain, kidney, testes, or spermatozoa were electrophoresed and transferred to a nitrocellulose membrane (Amersham Biosciences). Membranes were blocked and then incubated overnight with mouse polyclonal anti-RGS22 antibody (1:500) or rabbit polyclonal GNA13 antibody (A-20; Santa Cruz Biotechnology, Santa Cruz, CA) diluted at 1:250 (final concentration: 0.8 lg/ml). They were then washed and incubated for 1 h with horseradish peroxidaseconjugated anti-mouse or rabbit IgG (Beijing ZhongShan Biotechnology Co., Beijing, China) diluted at 1:2000. Specific proteins were detected using an ECL kit and AlphaImager (Amersham Biosciences). b-tubulin antibody (Abcam, Cambridge, U.K.) was used as a control for protein loading.
Fragment Construction and Subcellular Localization of pEGFP-C3-RGS22 Fusion Proteins
A plasmid containing pEGFP-C3 and RGS22 cDNA fragments was constructed using the following protocol. The RGS22 open-reading fragments (ORFs; N-terminal fragment from 21 bp to 1500 bp, C-terminal fragment from 1818 bp to 3783 bp) were amplified from the pTriplEx2-RGS22 vector by performing PCR with the forward primer 5 0 -GGGGAGATCTCGGCATGCCC-GAGAAGAG-3 0 (containing the BglII restriction site) and reverse primer 5 0 -GGGGGTCGACTCAATACAGAAGTAAA-3 0 (containing the SalI restriction site) for the N-terminal fragment, and the forward primer 5 0 -GGGGAGATCTG-TACATGTCAGAAAGCAG-3 0 (containing the BglII restriction site) and reverse primer 5 0 -GGGGGTCGACTCAATACAGAAGTAAA-3 0 (containing the SalI restriction site) for the C-terminal fragment. The amplified PCR products of the RGS22 fragments were purified and digested with BglII and SalI. These enzymes were also used to digest the plasmid pGEFP-C3 obtained from Clontech. The digested fragments in the pGEFP-C3 plasmid were then replaced with the corresponding fragments among the RGS22 fragment PCR products. The identity of the ORF insert was confirmed by DNA sequencing.
Complementary DNA from the constructed pEGFP-C3-RGS22 fragments was transfected into GC-1 spg cells (a mouse spermatogonial cell line procured from ATCC) using a transfection kit obtained from Invitrogen (Carlsbad, CA). In brief, the cells were seeded at a density of 4 3 10 5 cells per well in a six-well plate on the day prior to transfection and were cultured overnight. Monolayer GC-1 spg cells were grown in Dulbecco modified Eagle medium (DMEM; Gibco BRL) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS). Transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. As a control, the pEGFP-C3 vector lacking the insert was simultaneously transfected into cells in separate wells under identical conditions. After fixing the cells in polyformalin, they were treated with Hoechst fluorescent DNA stain (Molecular Probes, Eugene, OR) for 20 sec. The stained slides were observed under an Axioskop 2 plus microscope for analysis (Carl Zeiss, Thornwood, NY).
Immunohistochemical Analysis
After fixation in 10% neutral buffered formalin, matrices were dehydrated through an ascending series of graded ethanol, embedded in paraffin wax, and sectioned into 5-lm sections. Testis immunohistochemistry was performed as previously described [14] . RGS22 mouse polyclonal antibody (1:1000), rabbit polyclonal GNA13 antibody (1:100), and rabbit polyclonal GNA11 antibody (1:1000; C-19; Santa Cruz Biotechnology, Santa Cruz, CA) were used as primary antibodies, except the GNA13 antibody was used at a dilution of 1:500 for mouse testicular samples. Negative controls were incubated with diluted serum from normal mouse or rabbit serum and, unless otherwise stated, underwent the same immunohistochemical procedures.
In Vitro Pull-Down Assay and Coimmunoprecipitation
Human testes were homogenized and lysed in 20 mM Tris-HCl (pH 7.5) containing 5 mM EDTA, 100 mM NaCl, 5 mM benzamine, 0.2% Triton X-100, and protease inhibitors for 1 h on ice.
For the pull-down assay [9] , the supernatant obtained by centrifugation was incubated at 48C for 1 h with recombinant (His) 6 -fusion RGS22 prebound to nickel-sepharose beads in the presence or absence of GDP and/or ALF 4 -in an interaction buffer (20 mM Tris-HCl [pH 8.0], 2 mM MgSO 4 , 6 mM bmercaptoethanol, 100 mM NaCl, 0.05% Triton X-100, and 5% glycerol). Bound proteins were separated by 10% SDS-PAGE, and Ga subunits were visualized using the anti-GNA12 antibody (S-20; Santa Cruz Biotechnology, Santa Cruz, CA), anti-GNA13 antibody (A-20; Santa Cruz Biotechnology, Santa Cruz, CA), anti-GNA11 antibody (C-19; Santa Cruz Biotechnology, Santa Cruz, CA), and G-protein subunit antibodies (Calbiochem, San Diego, CA).
For coimmunoprecipitation [10] , the supernatant obtained by centrifugation was incubated with recombinant (His) 6 -fusion RGS22 in the presence of GDP and ALF 4 -in the interaction buffer. It was then divided into two fractions and immunoprecipitated with specific anti-GNA12, anti-GNA13, and anti-GNA11 antisera and the control antibody, followed by incubation with protein GSepharose. The resulting precipitates were subjected to immunoblot analysis with the anti-RGS22 antibody.
Isolation of Mouse Spermatogenic Cells
Mouse spermatogenic cells were isolated from adult mouse testes using a previously described method [15] . In brief, the testes were dissected and placed in DMEM containing 500 U/ml collagenase, 5 lg/ml DNAse I, and 1 mg/ml hyaluronidase, followed by incubation for 20-30 min at 348C with gentle stirring. Once the seminiferous tubules were dispersed in the medium, they were allowed to settle to the bottom, and the medium was aspirated and discarded. The tubules were then placed in fresh DMEM/F12 containing 1.5 mg/ml collagenase, 1 lg/ml DNAse I, 0.5 mg/ml trypsin, and 1.5 mg/ml hyaluronidase and incubated for 15-20 min with stirring and gentle pipetting. The spermatogenic cells released were pelleted by centrifugation (at 500 3 g for 10 min), washed twice in PBS, and attached to poly-L-lysine-coated coverslips.
Immunofluorescence Staining for GNA13 and Nuclear Material
Freshly prepared, washed spermatozoa were smeared on a microscope slide at a density of 30 000 cells/cm 2 and air-dried. Cell samples and sperm were fixed in polyformalin and then permeabilized with 0.1% Triton X-100 for 5 min at room temperature and washed. Following rehydration with 1% BSA for 30 min at room temperature, the samples were incubated with the anti-GNA13 antibody (diluted at 1:1000 in PBS containing 1% BSA at a final concentration of 0.2 lg/ml) at 48C overnight. After washing, they were incubated for 1 h with TRITC-labeled (or fluorescein isothiocyanate [FITC]-labeled) goat anti-rabbit IgG at a dilution of 1:100 (Beijing ZhongShan Biotechnology Co.). The samples were washed once again and then incubated with fluorescent Hoechst DNA stain (Molecular Probes) for 20 sec. The stained slides were observed under an Axioskop 2 plus microscope for analysis (Carl Zeiss). The exposure times used during photography were uniform to enable optimal comparison of fluorescence among the test samples.
RESULTS
Characterization of RGS22
In the present study, RGS22 was identified by differential hybridization of the human testis cDNA microarray based on the 10-fold difference in its expression level between embryos and adult testes [16] . RGS22 (GenBank accession No. AY009106) consists of 3957 nucleotides and contains an open-reading frame of 1253 amino acids (146 kDa). A Blast search of the contig map revealed that RGS22 is located within chromosome 8q22.2. It belongs to UniGene cluster HS.120021 (RGS22, DKFZP434I092), which was named primarily according to AY009106, NM_015668, and BC092411. Fundamentally, four completed alternative splicings of RGS22, AY009106, BC050053 (112 kDa), BC047060 (59 kDa), and AK097399 (76 kDa) were observed (Fig. 1A) . RGS22 was suggested to possess a long N-terminal region and three RGS domains at the C-terminal (Fig. 1A) by the Simple Modular Architecture Research Tool (SMART), an online resource (http://smart.embl-heidelberg.de/) used for protein domain identification and the analysis of protein domain architectures [17] . Tissue distribution studies performed using an RT-PCR kit for human tissues revealed that the gene was 
Ma, Marker; He, heart; Br, brain; Pl, placenta; Lu, lung; Li, liver; Sk, skeletal muscle; Ki, kidney; Pa, pancreas; Sp, spleen; Th, thymus; Pr, prostate; Te, testis; Ov, ovary; Sm, small intestine; Co, colon; Pe, peripheral blood leukocyte; Po, positive control in the kit was used in down line; Bl, blank.
RGS22 AND SPERMIOGENESIS strongly expressed in the testes but not in the other 15 tissues examined (Fig. 1B) .
Expression Patterns of RGS22 in Prokaryocytes and Eukaryocytes
For further protein characterization and functional studies, recombinant RGS22 was expressed as a (His) 6 -fusion protein in E. coli and then purified. Following IPTG induction, five specific RGS22 protein bands (146, 112, 76, 59, and 40 kDa) were obtained ( Fig. 2A) . Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry analysis of these five bands confirmed that they were all RGS22 protein ( Fig. 2B and Supplemental Fig. S1E 0 , S1A-D, and S1A 0 -D 0 available online at www.biolreprod.org). Purified recombinant RGS22 proteins were used to immunize mice. The antibody generated in our laboratory recognized five bands of 146, 112, 76, 59, and 40 kDa in the testes (Fig. 2C) . These findings indicate that RGS22 can form different products in prokaryocytes and can also produce proteins of different sizes in eukaryocytes.
Significantly Decreased Expression of RGS22 in Azoospermic Testes, Cellular Localization of RGS22 in Normal Testes, and Subcellular Localization of RGS22 Fragments
Previous RT-PCR results indicated that RGS22 is highly expressed in the human testis in a tissue-specific manner. To determine whether RGS22 is involved in spermatogenesis, RGS22 expression was examined with the testes of 19 patients with azoospermia. Our results demonstrated that the expression of RGS22 significantly decreased in the azoospermic testes of five sertoli-only syndrome patients and in azoospermic testes that resulted from spermatogenic disturbance and arrest. It is noteworthy that the expression of RGS22 was little or none in five of eight patients (62.5%), with testes containing sperm cells arrested prior to the spermatid stage. In contrast, RGS22 expression in obstructive azoospermic testes containing germ 1024 cells of all stages was similar to normal testis ( Fig. 3A and Table 1 ). Using the specific RGS22 antibody generated in our laboratory, we conducted immunohistochemical studies to examine the cellular localization of RGS22 in human and mouse testes. RGS22 was specifically expressed in Leydig cells and spermatogenic cells from the spermatogonia to spermatid stages. It was expressed in the cytoplasm of spermatogonia and spermatocytes, but in spermatids it was not only expressed in the cytoplasm but also in the nuclei (Fig.  3B ). These findings indicated that RGS22 expression may be associated with spermatogenesis, especially spermiogenesis.
To elucidate potential nuclear localization signals, we constructed RGS22 fragment-GFP fusion proteins and examined cellular localization. Our results showed that the RGS22 N-terminal fragment was localized in the nucleus, while the Cterminal fragment was localized in the cytoplasm (Fig. 3C) .
Interactions of RGS22 with G-protein a Subunits 12, 13, and q/11
To determine whether RGS22 interacts directly with Gprotein a subunits, human testis lysates were incubated with fusion proteins containing (His) 6 immobilized on nickelsepharose beads in the presence or absence of GDP and ALF 4 -, which mimics the transition state of G-protein a. Our results demonstrated that RGS22 binds specifically to GNA12, GNA13, and GNA11 in human testicular tissue in the presence of GDP-ALF 4 - (Fig. 4A) . The specificity of the interactions of RGS22 with GNA12, GNA13, and GNA11 was confirmed by incubating the testicular lysates with the corresponding antibodies bound to beads in the presence of GDP-ALF 4 -. The 146-, 112-, and 76-kDa forms of RGS22 mainly bound to GNA12, while the 146-and 76-kDa forms of RGS22 primarily Table 1 . B) Immunostaining of the RGS22 protein in the testes. RGS22 was localized in human and mouse spermatogenic cells at all stages, with cytoplasmic staining in spermatogonia and spermatocytes and cytoplasmic and nuclear staining in spermatids. In contrast, staining was absent in the negative controls treated with normal mouse serum. 10003 images showed higher magnification images of the framed sections in the corresponding 2003 ones. Sc, Sertoli cell; Sg, spermatogonia; Sp, spermatocyte; Sd, spermatid; L, Leydig cell. C) Subcellular localization of RGS22 fragments. RGS22 fragment-GFP fusion proteins or GFP as the control (green) and Hoechst-stained nuclei (blue) were observed in the GC-1 spg cells. Magnification 31000.
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bound to GNA13 in the presence of GDP-ALF 4 -. The predominant forms of RGS22 that bound to GNA11 were the 112-and 76-kDa forms. The 59-kDa form of RGS22 may be masked by the heavy chain of IgG (Fig. 4B) . These data indicate that RGS22 undergoes specific interactions with GNA12, GNA13, and GNA11 in the human testis.
Expression of the GNA13 and GNA11 Subunits in the Human Testis
According to our previous results, GNA12 was expressed in the cytoplasm of Leydig cells and in differentiating cells from elongated spermatids to mature spermatozoa. Previous studies have shown that GNA12 plays a role in polarity and tail formation during spermatid maturation [14] .
Furthermore, as shown in Figure 5A , Western immunoblotting demonstrated that the GNA13 and GNA11 protein subunits were expressed as bands of 43 kDa. These findings support the reliability and specificity of the antibodies used in the present study. Immunohistochemical analysis was also performed on human testis tissue. As shown in Figure 5B , strong GNA13 immunolabeling was observed in the cytoplasm of Leydig cells and in the seminiferous epithelium, including differentiating cells from the spermatogonia to mature spermatozoa stages. GNA13 expression was also present in the nuclei of round spermatids, whereas GNA11 was expressed exclusively in the cytoplasm of testicular cells (Fig. 5B) .
Differences in the Subcellular Localization of GNA13 Between Mouse Spermatogenic Cells and Somatic Cells
Since GNA13 protein is highly homologous in mouse and human tissue, we investigated its localization in adult mouse testis, brain, and kidney tissue to determine whether the cellular localization of GNA13 differs in the presence or absence of RGS22. As shown in Figure 6A , Western immunoblotting demonstrated that GNA13 protein is expressed in the mouse brain and kidneys, yielding bands of 43 kDa. Interestingly, our results also produced a single GNA13 band in the mouse testis and spermatozoa at identical molecular weights as in somatic tissue. GNA13 protein was also expressed in human testes and spermatozoa, with specific bands at 43 kDa (Fig. 5A) .
Immunohistochemical analyses of somatic tissues revealed that GNA13 protein was localized in the cytoplasm of mouse choroid cells in the brain and in renal tubular cells in the absence of RGS22 (Fig. 6B) . Furthermore, strong GNA13 immunolabeling was observed in the cytoplasm of Leydig cells and in the seminiferous epithelium of mouse testes, including differentiating cells from the spermatogonia to mature spermatozoa stages. During spermatogenesis, nuclear expression of GNA13 increased from the spermatocyte to elongated spermatid stages, and was primarily localized to the nuclei in spermatids. Thus, GNA13 was expressed in the cellular cytoplasm of adult somatic cells, but it was mainly in the nucleus of spermatids in the testes.
To confirm that GNA13 translocates from the cytoplasm to the nucleus during spermatogenesis, we isolated spermatid populations at various developmental stages (i.e., round spermatids, elongating spermatids, elongated spermatids, and testicular spermatozoa) from adult mice and stained them for detection of GNA13. As shown in Figure 6C , GNA13 immunoreactivity was predominantly observed in the cytoplasm of round spermatids but was expressed in the nuclei of elongating or elongated spermatids and testicular spermatozoa (Fig. 6C) .
GNA13 Is Decreased in Spermatozoa with Impaired Nuclear Formation
The spermatozoa of teratozoospermia patients were used to investigate whether expression levels of GNA13 protein are associated with specific types of sperm abnormalities. As shown in Figure 6D , altered expression of GNA13 was observed in macrocephalic spermatozoa. In samples from six healthy adult males, GNA13 was expressed in the nuclei of   FIG. 4. Interactions of RGS22 with G-protein a subunits 12, 13 , and q/ 11. A) Interactions between RGS22 and G-protein a subunits. Human testes were lysed, activated with GDP-AlF 4 -or left untreated, and incubated with recombinant (His) 6 RGS22 immobilized on nickelsepharose beads. After washing with lysis buffer, the bound proteins were eluted in SDS sample buffer, boiled, fractionated on a 10% SDS gel, and immunoblotted for the various G-protein a subunits, as indicated on the left. A human testis lysate was used as the positive control for the Gprotein a subunits. B) Coimmunoprecipitation of RGS22 and G-protein a subunits 12, 13, and q/11. Recombinant (His) 6 -fusion RGS22 in the presence of GDP and ALF 4 -was immunoprecipitated with specific anti-GNA12, anti-GNA13, and anti-GNA11 antisera and the control antibody, followed by incubation with protein G-Sepharose. The 146-, 112-, and 76-kDa (labeled KD in figure) protein forms of RGS22 were coimmunoprecipitated with GNA12, and the 146-and 76-kDa (labeled KD in figure) protein forms of RGS22 were coimmunoprecipitated with GNA13. However, the 112-and 76-kDa forms of RGS22 interacted with GNA11. 99.2% (1000/1008) of spermatozoa. However, in macrocephalic spermatozoa obtained from infertile patients (n ¼ 6), GNA13 was only expressed in 28.6% (30/105) of macrocephalic spermatozoa. This difference was statistically significant using a chi-square test (P , 0.001).
DISCUSSION
Spermatogenesis involves the differentiation of diploid spermatogonia into spermatocytes and the subsequent development into haploid round spermatids via two successive meiotic divisions. The postmeiotic developmental phase, spermiogenesis, involves the differentiation of spermatids into spermatozoa. During this remarkable phase, germ cells undergo extensive morphogenetic transformations that involve dramatic nuclear remodeling, chromatin condensation, acrosome formation, removal of residual cytosolic bodies, and synthesis and assembly of the flagellar axoneme and accessory fiber proteins. Previous work from our laboratory showed that RGS22 expression is higher in adult testes compared to embryonic testes [16] . Since spermatogenesis begins at puberty, this finding strongly suggested that RGS22 may be involved in spermatogenesis. Moreover, RGS22 expression was significantly decreased in the testes of five sertoli-only syndrome patients and in azoospermic testes caused by spermatogenic disturbance and arrest (particularly before the spermatid stage). Taken together, these findings support the hypothesis that RGS22 may be involved in spermatogenesis and especially spermiogenesis. However, further research is required to determine the precise role(s) of RGS22 in the testis.
Previous studies have demonstrated that RGS proteins bind directly and preferentially to the active GTP-bound forms of G- FIG. 6 . Localization of GNA13 protein in mouse somatic tissues, testes, and spermatozoa. A) GNA13 protein expression in mouse somatic tissues, testes, and spermatozoa. Representative Western blots showing that GNA13 protein (43 kDa) is expressed in the brain, kidneys, testes, and spermatozoa of mice. B) Immunostaining of the GNA13 protein in mouse somatic tissues and testes. GNA13 protein was localized in the cytoplasm of mouse choroid cells in the brain and in renal tubular cells of the kidney. It was also expressed in Leydig cells and in the seminiferous epithelium at various stages of spermatogenesis in the mouse testis. Cytoplasmic expression in the Leydig cells and differentiating cells occurred in spermatogonia to early round spermatids. GNA13 expression in the nucleus increased during spermatocyte to elongated spermatid development. In contrast, no staining was observed in the controls treated with normal rabbit serum. The magnification shown in the left and right columns is 2003; the middle column is 10003. C) GNA13 translocation from the cytoplasm of round spermatids to the nuclei of spermatogenic cells at subsequent stages of development in the mouse. Single-cell immunofluorescence analysis revealed GNA13 expression in the cytoplasm of mouse round spermatids. Concurrent with nuclear remodeling, GNA13 was highly expressed and mainly localized in the nuclei of elongating and elongated spermatids. On completion of nuclear condensation, GNA13 immunoreactivity was weak in the condensed sperm nucleus. From left to right: column 1, rabbit anti-GNA13, FITC-conjugated goat anti-rabbit secondary antibody (green); column 2, Hoechst (blue); column 3, merged image of column 1, 2, and the corresponding bright-field figure. Magnification 31000. D) Impaired expression of GNA13 protein in spermatozoa with macrocephaly. GNA13 expression was decreased or absent in spermatozoa with macrocephaly (arrowheads). From left to right: column 1, rabbit anti-GNA13, TRITC-conjugated goat anti-rabbit secondary antibody (red); column 2, Hoechst (blue); column 3, the corresponding bright-field figure; column 4, merged from column 1 and 2. Magnification is 31000. Bar ¼ 2 lm.
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protein a and that the RGS domains exhibit highest affinity for GDP-Mg 2þ -AlF4 --bound G-protein a, which mimics the transition state occurring during GTP hydrolysis [18, 19] . Here, we demonstrated specific interactions of RGS22 with GNA12, GNA13, and GNA11 in the presence of GDP and ALF 4 -in the human testes. Two of these members make up the G12 subfamily, GNA12 and GNA13, and have been shown to participate in cell transformation and embryonic development. In contrast, the GTPase activity of the GNA11 protein subunit can be accelerated not only by RGS proteins but also by the effector molecule phospholipase C-b [20] [21] [22] . However, the signaling pathways regulated by these proteins have not been identified in spermatogenic cells. Our previous research demonstrated that GNA12 plays a role in polarity and tail formation during spermatid maturation [14] . However, further investigations were required to study the role of GNA13 in spermatogenesis and to examine its relationships to RGS22.
GNA13 has previously been reported to be localized in the cytoplasm or membranes of diverse somatic cells [23] . In our study, we found that the GNA13 subunit plays different roles in spermatogenic cells versus somatic cells. Our results showed that GNA13 migrated from the cytoplasm to the nucleus during spermiogenesis. Previous reports also suggest that similar to membrane receptors, the nucleus may be capable of inducing G-protein activation, and G-protein subunits co-migrate to the nucleus, where they are activated and control distinct nuclear events [24] . During nuclear remodeling of spermiogenesis, select male germ cell-specific nuclear proteins (e.g., transition proteins and protamines) sequentially replace histones to enable DNA compaction and reshaping of round spermatid nuclei [25] . We speculate that GNA13 may be one of the proteins that participate in the co-migration of spermatogenic cell-specific agents into the nuclei of elongating spermatids. In some cases, RGS proteins exhibiting nuclear localization have been shown to function as shuttles for transport of Gai subunits into the nucleus [26] . Here, we have identified the specific expression of RGS22 in the testis and have confirmed that it interacts with GNA13. RGS22 also translocated from the cytoplasm of spermatogonia and spermotocytes into the nuclei of spermatids. These results strongly suggest that RGS22 may facilitate GNA13 translocation from the cytoplasm of spermatogonia and spermotocytes into the nuclei of spermatids during spermiogenesis.
Chatterjee [7] identified the conserved RGS domain present in all RGS proteins as the molecular determinant for the nuclear localization of these proteins. Moreover, certain sequence elements other than the RGS domain also facilitate either the nuclear-cytoplasmic transport or cytoplasmic retention of RGS proteins. The differential localization of RGS proteins within cells is due to structural differences among these proteins; these differences do not appear to be important determinants of their G protein regulatory activities. It has been suggested that RGS proteins are involved in more complex cellular functions than originally envisioned. In our study, the nuclear localization signal corresponded to the N-terminal of RGS22. However, the manner by which GNA13 translocated into the nucleus and whether RGS22 is involved in this process remain unclear. The possible involvement of RGS22 in the regulation of GNA13 nuclear translocation and the underlying mechanism(s) are interesting topics for further investigation.
The translocation of RGS22 and GNA13 from the cytoplasm to the nucleus may reflect GNA13 signal transduction, as in the case of other proteins. For example, proteins such as cytochrome c, MST1, and PDCD5 are involved in the induction of chromatin remodeling during their translocation from the cytoplasm to the nucleus [27] [28] [29] . Spermatogenesis is a multistep cell differentiation process that involves many nuclear events such as the mitotic proliferation of spermatogonia, meiosis of spermatocytes, and transformation of spermatids, which involves dramatic nuclear remodeling and chromatin condensation. Since RGS22 and GNA13 were observed in the nucleus from the elongated-spermatid stage onward, their function in this subcellular compartment is likely related to the postmeiotic developmental phase, spermiogenesis. The dysfunctional expression of GNA13 in macrocephalic spermatozoa from infertile patients supports this hypothesis.
Furthermore, it is well documented that RGS can be regulated by posttranslational modifications such as protein interactions and regulation of protein transcription or translation. Another common mechanism by which cells can fine-tune signaling responses using a limited gene template is through alternate gene splicing. Several RGS proteins are produced as multiple gene products [30] . Four completed alternative splicings of RGS22 have been submitted to NCBI, all of which were cloned from testicular tissue. Here, we demonstrate that RGS22 can be translated or posttranslationally modified into proteins of different sizes in prokaryocytes and eukaryocytes. Although the functional significance of most of these splice variants is currently unknown, research on RGS proteins is providing further insights into how structural variations can fundamentally alter the regulation and functions of proteins.
In conclusion, we have successfully cloned a new RGS gene, RGS22. It is specifically expressed in the testis and is involved in spermatogenesis. The present findings suggest that RGS22 interacts with GNA12, GNA13, and GNA11 and may play a role in GNA13 translocation into the nucleus during spermiogenesis.
